Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels.

Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N.

Am J Psychiatry. 1999 Sep;156(9):1440-3.

PMID:
10484959
2.

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.

Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N.

Am J Psychiatry. 1999 Jan;156(1):19-26.

PMID:
9892293
3.

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N.

Am J Psychiatry. 1997 Jan;154(1):50-5.

PMID:
8988958
4.

Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.

Hietala J, Någren K, Lehikoinen P, Ruotsalainen U, Syvälahti E.

J Cereb Blood Flow Metab. 1999 Feb;19(2):210-7.

PMID:
10027776
5.

Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.

Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N.

J Nucl Med. 1999 Aug;40(8):1285-91.

6.

Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.

Arch Gen Psychiatry. 2007 Aug;64(8):932-40.

PMID:
17679638
7.

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.

Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM.

Psychopharmacology (Berl). 2003 Mar;166(3):264-70. Epub 2003 Feb 13.

PMID:
12589522
8.

Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.

Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR.

J Pharmacol Exp Ther. 1999 Oct;291(1):409-15.

9.

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.

Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM.

Am J Psychiatry. 2004 Jul;161(7):1173-80.

PMID:
15229048
10.

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

Hietala J, Syvälahti E, Vuorio K, Någren K, Lehikoinen P, Ruotsalainen U, Räkköläinen V, Lehtinen V, Wegelius U.

Arch Gen Psychiatry. 1994 Feb;51(2):116-23.

PMID:
7905257
11.

Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.

Rinne JO, Hublin C, Partinen M, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Laihinen A.

Neurology. 1995 Sep;45(9):1735-8.

PMID:
7675236
12.

Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.

Pohjalainen T, Rinne JO, Någren K, Syvälahti E, Hietala J.

Am J Psychiatry. 1998 Jun;155(6):768-73.

PMID:
9619148
13.

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study.

Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N.

Synapse. 2002 Nov;46(2):79-82. Erratum in: Synapse. 2003 Mar 15;47(4):295.. Thanos Pether [corrected to Thanos Panayotis Peter K].

PMID:
12211085
14.

Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.

Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Schlyer DJ, Hitzemann R, Wolf AP.

Psychiatry Res. 1996 May 31;67(1):11-6.

PMID:
8797238
15.

Age-related reduction of extrastriatal dopamine D2 receptor measured by PET.

Inoue M, Suhara T, Sudo Y, Okubo Y, Yasuno F, Kishimoto T, Yoshikawa K, Tanada S.

Life Sci. 2001 Jul 20;69(9):1079-84.

PMID:
11508650
16.

Decreases in dopamine receptors but not in dopamine transporters in alcoholics.

Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K.

Alcohol Clin Exp Res. 1996 Dec;20(9):1594-8.

PMID:
8986209
17.

Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.

Smith GS, Dewey SL, Brodie JD, Logan J, Vitkun SA, Simkowitz P, Schloesser R, Alexoff DA, Hurley A, Cooper T, Volkow ND.

Am J Psychiatry. 1997 Apr;154(4):490-6.

PMID:
9090335
18.

Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents.

Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND.

Pharmacol Biochem Behav. 2007 Oct;87(4):426-33. Epub 2007 Jun 5.

PMID:
17599397
19.

Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride.

Khan N, Antonini A, Parkes D, Dahlitz MJ, Meier-Ewert K, Weindl A, Leenders KL.

Neurology. 1994 Nov;44(11):2102-4.

PMID:
7969966
20.

Supplemental Content

Support Center